Finance

Beta
Ask
Lists
ODTX:NASDAQ
Odyssey Therapeutics Inc
$18.14
-3.10%
(-0.58) 1D
Jun 23, 12:27:13 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ODTX...
Open
$18.50
High
$18.50
Low
$17.55
Mkt. cap
860.72M
Avg. vol.
468.84K
Volume
88.74K
52-wk high
$20.30
52-wk low
$15.41
EPS
-$3.15
No. of employees
100
Open
$18.50
High
$18.50
Low
$17.55
Mkt. cap
860.72M
Avg. vol.
468.84K
Volume
88.74K
52-wk high
$20.30
52-wk low
$15.41
EPS
-$3.15
No. of employees
100
News stories
From sources across the web
About Odyssey Therapeutics Inc
CEO-
Employees100
Founded2021
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiteodysseytx.com
Analyst Ratings
Based on 5 analysts giving stock ratings to ODTX in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ODTX in the last 3 months.
Highest
Current $18.14
$40.00 (+120.51%)
Average
$32.00 (+76.41%)
Lowest
$26.00 (+43.33%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
06/18/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
$40.00
+120.5%
06/18/2026
David Nierengarten
Wedbush
Buy
Maintained
$30.00
+65.4%
06/16/2026
Eric Schmidt FCA
Cantor Fitzgerald
Buy
Initiated
-
-
06/02/2026
Brian Cheng
J.P. Morgan
Buy
Initiated
$26.00
+43.3%
06/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
1.92M
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
38.77M
32.32M
Total research and development expenses
-
-
Selling, general, and admin expenses
7.95M
7.35M
Operating expense
46.73M
39.67M
Total operating expenses
46.73M
39.67M
Operating income
-44.81M
-39.67M
Other non operating income
-289.00K
-117.00K
EBT including unusual items
-38.30M
-38.20M
EBT excluding unusual items
-43.94M
-38.09M
Income tax expense
140.00K
63.00K
Effective tax rate
-0.37%
-0.16%
Other operating expenses
-
-
Net income
-38.44M
-38.26M
Net profit margin
-2,003.91%
-
Earnings per share
-
-6.75
Interest and investment income
1.16M
1.71M
Interest expense
-2.00K
-10.00K
Net interest expenses
1.15M
1.70M
Depreciation and amortization charges
-
-
EBITDA
-43.51M
-38.50M
Gain or loss from assets sale
495.00K
-33.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer